Literature DB >> 20952536

Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit.

Mehdi Khaled1, Carmit Levy, David E Fisher.   

Abstract

Cyclic AMP (cAMP) is a ubiquitous second messenger that regulates a variety of biological processes. The magnitude and duration of cAMP expression are regulated by both production and hydrolysis. Melanocyte-stimulating hormone (MSH) plays a crucial role in pigment cell differentiation via cAMP-regulated expression of the master transcription factor MITF. We report the identification of phosphodiesterase 4D3 as a direct target of the MSH/cAMP/MITF pathway. This creates a negative feedback loop that induces refractoriness to chronic stimulation of the cAMP pathway in melanocytes. This homeostatic pathway highlights a potent mechanism controlling melanocyte differentiation that may be amenable to pharmacologic manipulation for skin cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952536      PMCID: PMC2956206          DOI: 10.1101/gad.1937710

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  31 in total

1.  A long-term time course of colorimetric evaluation of ultraviolet light-induced skin reactions.

Authors:  S B Park; D H Suh; J I Youn
Journal:  Clin Exp Dermatol       Date:  1999-07       Impact factor: 3.470

2.  Effect of alpha- and betamelanocyte stimulating hormones on the skin colour of man.

Authors:  A B LERNER; J S MCGUIRE
Journal:  Nature       Date:  1961-01-21       Impact factor: 49.962

3.  Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator.

Authors:  N J Bentley; T Eisen; C R Goding
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

4.  Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.

Authors:  Jinyan Du; Hans R Widlund; Martin A Horstmann; Sridhar Ramaswamy; Ken Ross; Wade E Huber; Emi K Nishimura; Todd R Golub; David E Fisher
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

5.  Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation.

Authors:  C Sette; M Conti
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

6.  The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579.

Authors:  R Hoffmann; G S Baillie; S J MacKenzie; S J Yarwood; M D Houslay
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

7.  Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.

Authors:  D E Griswold; E F Webb; J Breton; J R White; P J Marshall; T J Torphy
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

8.  alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome.

Authors:  E R Price; M A Horstmann; A G Wells; K N Weilbaecher; C M Takemoto; M W Landis; D E Fisher
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

9.  Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor.

Authors:  T Kunisada; S Z Lu; H Yoshida; S Nishikawa; S Nishikawa; M Mizoguchi; S Hayashi; L Tyrrell; D A Williams; X Wang; B J Longley
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

10.  Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes.

Authors:  C Bertolotto; P Abbe; T J Hemesath; K Bille; D E Fisher; J P Ortonne; R Ballotti
Journal:  J Cell Biol       Date:  1998-08-10       Impact factor: 10.539

View more
  38 in total

1.  Without the sun.

Authors:  Kira Anthony
Journal:  Nat Rev Cancer       Date:  2010-12       Impact factor: 60.716

Review 2.  Paracrine regulation of melanocyte genomic stability: a focus on nucleotide excision repair.

Authors:  Stuart Gordon Jarrett; Katharine Marie Carter; John August D'Orazio
Journal:  Pigment Cell Melanoma Res       Date:  2017-04-20       Impact factor: 4.693

3.  Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF.

Authors:  Erez Feige; Satoru Yokoyama; Carmit Levy; Mehdi Khaled; Vivien Igras; Richard J Lin; Stephen Lee; Hans R Widlund; Scott R Granter; Andrew L Kung; David E Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

4.  PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.

Authors:  J Delyon; A Servy; F Laugier; J André; N Ortonne; M Battistella; S Mourah; A Bensussan; C Lebbé; N Dumaz
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

5.  Pharmacologic induction of epidermal melanin and protection against sunburn in a humanized mouse model.

Authors:  Alexandra Amaro-Ortiz; Jillian C Vanover; Timothy L Scott; John A D'Orazio
Journal:  J Vis Exp       Date:  2013-09-07       Impact factor: 1.355

6.  FOXQ1 controls the induced differentiation of melanocytic cells.

Authors:  Archis Bagati; Anna Bianchi-Smiraglia; Sudha Moparthy; Kateryna Kolesnikova; Emily E Fink; Masha Kolesnikova; Matthew V Roll; Peter Jowdy; David W Wolff; Anthony Polechetti; Dong Hyun Yun; Brittany C Lipchick; Leslie M Paul; Brian Wrazen; Kalyana Moparthy; Shaila Mudambi; Galina E Morozevich; Sofia G Georgieva; Jianmin Wang; Gal Shafirstein; Song Liu; Eugene S Kandel; Albert E Berman; Neil F Box; Gyorgy Paragh; Mikhail A Nikiforov
Journal:  Cell Death Differ       Date:  2018-02-20       Impact factor: 15.828

Review 7.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

Review 8.  Topical treatment strategies to manipulate human skin pigmentation.

Authors:  Inbal Rachmin; Stephen M Ostrowski; Qing Yu Weng; David E Fisher
Journal:  Adv Drug Deliv Rev       Date:  2020-02-21       Impact factor: 15.470

9.  Pigment-independent cAMP-mediated epidermal thickening protects against cutaneous UV injury by keratinocyte proliferation.

Authors:  Timothy L Scott; Perry A Christian; Melissa V Kesler; Kevin M Donohue; Brent Shelton; Kazumasa Wakamatsu; Shosuke Ito; John D'Orazio
Journal:  Exp Dermatol       Date:  2012-10       Impact factor: 3.960

10.  PGC-1 coactivators regulate MITF and the tanning response.

Authors:  Jonathan Shoag; Rizwan Haq; Mingfeng Zhang; Laura Liu; Glenn C Rowe; Aihua Jiang; Nicole Koulisis; Caitlin Farrel; Christopher I Amos; Qingyi Wei; Jeffrey E Lee; Jiangwen Zhang; Thomas S Kupper; Abrar A Qureshi; Rutao Cui; Jiali Han; David E Fisher; Zoltan Arany
Journal:  Mol Cell       Date:  2012-11-29       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.